Abpro Holdings, Inc. cotiza a 0.37 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Abpro Holdings, Inc., a biotechnology company, focuses on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease in the United States. Its platforms include DiversImmune, an antibody discovery platform that generates a diverse collection …
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-04 |
|---|---|---|---|---|
| Real | $-0.63 | $-1.50 | $-2.40 | $-9.60 |
| Estimado | $-1.20 | $-1.20 | $-1.20 | $-1.20 |
| Sorpresa | +47.5% | -25.0% | -100.0% | -700.0% |
| Métrica | ABPO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -272.1% | -32.0% | -240.1% |
| Current Ratio | 0.10 | 2.84 | -2.74 |
| Debt / Equity | — | 0.28 | — |